Search - tctmd.com

Displaying 121 - 140 of 166

Sort: Relevancy | Date

News Daily News

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

March 13, 2014

News Daily News

La Mayoría de Lesiones No Causantes con Rotura de la Placa No acarrean Más Episodios

March 13, 2014

News Daily News

Fever After TAVR Common, but Antibiotics Rarely Needed

L.A. McKeown

January 15, 2014

News Daily News

经桡动脉途径PCI何时及如何使ACS及STEMI患者受益

January 01, 2014

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Caitlin E. Cox

April 19, 2013

News Daily News

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

March 09, 2013

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

Presentation TCT 2013

Prevalence, Correlation and Clinical Outcome of Intra-procedural Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Coronary Syndrome

Presenter: Yingjia Xu, Xinkai Qu, Xingbiao Qiu, Hui Chen, Shaofeng Guan, Jingjie Dai, Weiyi Fang

January 31, 2013

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

Advertisement

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

La Mayoría de Lesiones No Causantes con Rotura de la Placa No acarrean Más Episodios

Fever After TAVR Common, but Antibiotics Rarely Needed

经桡动脉途径PCI何时及如何使ACS及STEMI患者受益

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Prevalence, Correlation and Clinical Outcome of Intra-procedural Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Coronary Syndrome

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content